Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 10:57:53-55.
doi: 10.1016/j.jdcr.2024.12.028. eCollection 2025 Mar.

A large pruritic plaque in a patient with 2 kidney transplants

Affiliations

A large pruritic plaque in a patient with 2 kidney transplants

Chiel F Ebbelaar et al. JAAD Case Rep. .
No abstract available

Keywords: cornoid lamellae; giant porokeratosis; immunosuppression; kidney transplantation; skin cancer; topical simvastatin.

PubMed Disclaimer

Conflict of interest statement

None disclosed.

Figures

Fig 1
Fig 1
Fig 2
Fig 2
Fig 3
Fig 3

References

    1. Aitkens L., Byrne J., Jennings-Dover C., Potter K.A. A case of squamous cell carcinoma arising in a giant porokeratosis previously diagnosed as psoriasis. Dermatol Reports. 2022;15:9634. - PMC - PubMed
    1. Santa Lucia G., Snyder A., Lateef A., et al. Safety and efficacy of topical lovastatin plus cholesterol cream vs topical lovastatin cream alone for the treatment of disseminated superficial actinic porokeratosis: a randomized clinical trial. JAMA Dermatol. 2023;159:488–495. - PMC - PubMed
    1. Casale F., Walters N., Peach A., Dong J. Efficacy of topical cholesterol and statin combination therapy in the treatment of porokeratosis: a systematic review and meta-analysis. J Drugs Dermatol. 2023;22:1160–1165. - PubMed
    1. Pietkiewicz P., Korecka K., Salwowska N., et al. Porokeratoses-A comprehensive review on the genetics and metabolomics, imaging methods and management of common clinical variants. Metabolites. 2023;13:1176. - PMC - PubMed
    1. Atzmony L., Lim Y.H., Hamilton C., et al. Topical cholesterol/lovastatin for the treatment of porokeratosis: a pathogenesis-directed therapy. J Am Acad Dermatol. 2020;82:123–131. - PMC - PubMed

LinkOut - more resources